Monopar Therapeutics Inc. ('Monopar” or the 'Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, is presenting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback